Cell-free (cf)DNA analysis identifies PIK3CA/AKT1 mutations associated with greater PFS improvement from the addition of ipatasertib (IPAT) to paclitaxel (P) in triple-negative breast cancer (TNBC) Meeting Abstract
| Authors: | Wongchenko, M.; Dent, R.; Kim, S. B.; Saura, C.; Oliveira, M.; Baselga, J.; Kapp, A. V.; Chan, W. Y.; Singel, S. M.; Maslyar, D. J.; Gendreau, S. |
| Abstract Title: | Cell-free (cf)DNA analysis identifies PIK3CA/AKT1 mutations associated with greater PFS improvement from the addition of ipatasertib (IPAT) to paclitaxel (P) in triple-negative breast cancer (TNBC) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx363.038 |
| Language: | English |
| ACCESSION: | WOS:000411324000181 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx363.038 |
| Notes: | Meeting Abstract: 122P -- Appears on pages 33-34 of the abstract book -- Source: Wos |
